Cargando…
Response to “iPTH is not a significant factor influencing the tacrolimus C/D ratio”
Autores principales: | Tanaka, Ryota, Suzuki, Yosuke, Watanabe, Hiroshi, Fujioka, Takashi, Hirata, Kenshiro, Shin, Toshitaka, Ando, Tadasuke, Ono, Hiroyuki, Tatsuta, Ryosuke, Mimata, Hiromitsu, Maruyama, Toru, Itoh, Hiroki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010249/ https://www.ncbi.nlm.nih.gov/pubmed/35182111 http://dx.doi.org/10.1111/cts.13242 |
Ejemplares similares
-
Association of CYP3A5 polymorphisms and parathyroid hormone with blood level of tacrolimus in patients with end‐stage renal disease
por: Tanaka, Ryota, et al.
Publicado: (2021) -
iPTH is not a significant factor influencing the tacrolimus C/D ratio
por: Westphal, Florian, et al.
Publicado: (2022) -
Sustained suppression of enterohepatic circulation of mycophenolic acid by antimicrobial‐associated diarrhea in a kidney transplant recipient with Crohn's disease: A case report
por: Tanaka, Ryota, et al.
Publicado: (2022) -
Hypocalcemia after thyroidectomy: iPTH levels and iPTH decline are predictive? Retrospective cohort study()
por: Cannizzaro, Matteo Angelo, et al.
Publicado: (2018) -
Sensitive UHPLC-MS/MS quantification method for 4β- and 4α-hydroxycholesterol in plasma for accurate CYP3A phenotyping
por: Suzuki, Yosuke, et al.
Publicado: (2022)